2-Amino-5-nitrobenzotrifluoride

We are 2-Amino-5-nitrobenzotrifluoride CAS:121-01-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  2-Amino-5-nitrobenzotrifluoride
CAS.NO: 121-01-7
Synonyms:4-Nitro-2-(trifluoromethyl)aniline;
2-Amino-5-Nitro Benzotrifluoride;
2-AMINO-5-NITRO-TRIFLUOROBENZENE;
2-TRIFLUOROMETHYL-4-NITROANILINE;
4-Nitro-2-Trifluoromethylaniline;
Molecular Formula:C7H5F3N2O2
Molecular Weight:206.12200
 
Physical and Chemical Properties:
Density:1.503g/cm3
Melting point:90-92 °C(lit.)
Boiling point:298ºC at 760 mmHg
Flash point:134ºC
Index of Refraction:1.427
 
Specification:
Appearance:Yellow crystal or powder
Purity:≥99.0%
 
Packing:5kg/drum, 10kg/drum,25kg/drum
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:  Applicationd as medicine, pesticide intermediate

2-Amino-5-nitrobenzotrifluoride


Related News: For example, an active ingredient to relieve pain is included in a painkiller.Bromoform CAS:75-25-2 INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.78-62-6 The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.Methyl 6-methylnicotinate CAS:5470-70-2 The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.

Related Products
Product Name
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-(9H-fluoren-9-ylmethoxycarbonyl)imidazol-4-yl]propanoic acid View Details
2-chloro-1-(3,4-difluorophenyl)ethanone View Details
Pyridine hydrofluoride Cas:32001-55-1 View Details
Butylated hydroxyanisole Cas:25013-16-5 manufacturer Ethyl 2-Sulfamoylbenzoate manufacturer 1,4-Phenylene Diisothiocyanate manufacturer 4-Tert-Butylbenzenesulfonamide manufacturer 3-Amino-4-chlorobenzotrifluoride manufacturer